Skip to content

NorthboundBio

Active Private limited companyfounded 2024active for 2 yearsRerum Novarumlaan 26, 3010 LeuvenKBO/BCE: BE 1008.524.836

Lifetime

2 annual accounts with figures on one time axis
peak of €181,588 in 2025
€181,588▲ 70.5%
peak of €141,107 in 2025
€141,107▲ 71.2%
peak of €226,519 in 2025
€226,519▲ 165%
€60,073▲ 28.7%
Board1 name since 2024
1 director
Documentsfilings and deeds
28-05-202664 days before the deadline
2025micro format
Gross margin from €106,512 to €181,588Result from €82,413 to €141,107Equity from €85,413 to €226,519Debts from €46,687 to €60,073Investments €22,728Cash from €96,149 to €231,651

Key points

from the 2025 annual accounts

Equity

€226,519 ▲ 165%
€85,4002024€227,0002025

Equity rose in 2025 from €85,413 to €226,519.

Turnover

≈ €450,000 estimated

The micro format states no turnover.

Liquidity

4.18 was 2.56 in 2024

Short-term debts rose from €46,687 to €60,073.

Subsidiaries

-€83,639

Subsidiary with negative equity. ReMYND · loss of €6.6m in 2025.

Position in the sector

€141,107

Higher net result than 87% of companies in research and development. Sector median €23,659 · 669 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as NorthboundBio has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for NorthboundBio. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 18-04-2024
  • 120 sharesdeed of 22-04-2024

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1008524836
Incorporation Founding capital of €3,045, 120 shares · Founded by · appointed as director · published on 22-04-2024 · Gazette deed
First establishment Rerum Novarumlaan 26, Leuven
All 6 events

Comparable companies

same main activity, similar in size and age
Company
NorthboundBio Leuven €286,592 €181,588 79.0% -
PLT ANALYSIS Waterloo €305,968 €140,126 68.4% -
Flindr Labs Ghent €262,929 €294,811 -148.7% 4.2
ClinInnov Ciney €361,049 €176,553 65.8% -
Centre for Advanced Research & Development Brussels €341,656 €163,556 36.2% -
TereLabs Brussels €207,737 €83,807 78.1% -
Bio-Perspectives Ixelles €206,760 €104,857 81.3% -

These companies have the same main activity as NorthboundBio: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €207,000 and €361,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 18-04-2024Normal situation
Activity
Research and development on biotechnologyNACE 72101and 2 others
Establishment unit
2.358.855.6013010 Leuven, since 18-04-2024
Financial year end
31 December
Peppol
Reachable since 21-12-2024
Company details

Annual accounts 2025

€286,592▲ 117%
Filing
Filed on 28-05-2026, 64 days before the end of the filing period
Financials

Insights on NorthboundBio

NorthboundBio has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €226,519 and a net result of €141,107.

Its solvency ranks better than 68% of 667 sector peers (NACE 72) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NorthboundBio

What is the company number of NorthboundBio?
The company number of NorthboundBio is 1008.524.836. The VAT number is the same number with BE in front: BE 1008.524.836.
Where is NorthboundBio based?
The registered office is at Rerum Novarumlaan 26, 3010 Leuven.Company details
What does NorthboundBio do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of NorthboundBio?
NorthboundBio is a private limited company (BV).
When was NorthboundBio founded?
NorthboundBio was founded on 18-04-2024.
Is NorthboundBio still active?
Yes, NorthboundBio is an active enterprise in the KBO register.
What is the turnover of NorthboundBio?
The turnover in financial year 2025 is ≈ €450,000. This figure is estimated from the gross margin of €181,588 and 2,459 comparable companies of the same size. It probably lies between €300,000 and €700,000. It is a rough estimate.Financials
Is NorthboundBio profitable?
In financial year 2025, NorthboundBio made a profit of €141,107.
Where can I find the annual accounts of NorthboundBio?
NorthboundBio filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NorthboundBio due?
NorthboundBio must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.